BARNWELL INDUSTRIES INC (BRN)

US0682211000 - Common Stock

2.78  +0.02 (+0.72%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to BRN. BRN was compared to 213 industry peers in the Oil, Gas & Consumable Fuels industry. The financial health of BRN is average, but there are quite some concerns on its profitability. BRN is valued expensive and it does not seem to be growing.



2

1. Profitability

1.1 Basic Checks

BRN had negative earnings in the past year.
In the past year BRN had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: BRN reported negative net income in multiple years.
Of the past 5 years BRN 4 years had a positive operating cash flow.

1.2 Ratios

BRN has a Return On Assets of -9.91%. This is amonst the worse of the industry: BRN underperforms 89.62% of its industry peers.
BRN has a worse Return On Equity (-19.83%) than 85.38% of its industry peers.
Industry RankSector Rank
ROA -9.91%
ROE -19.83%
ROIC N/A
ROA(3y)12.56%
ROA(5y)-12.29%
ROE(3y)29.83%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

BRN has a Gross Margin (33.98%) which is in line with its industry peers.
In the last couple of years the Gross Margin of BRN has grown nicely.
The Profit Margin and Operating Margin are not available for BRN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 33.98%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.23%
GM growth 5Y1.55%

6

2. Health

2.1 Basic Checks

BRN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for BRN has been increased compared to 1 year ago.
BRN has more shares outstanding than it did 5 years ago.
BRN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

BRN has an Altman-Z score of 1.72. This is a bad value and indicates that BRN is not financially healthy and even has some risk of bankruptcy.
BRN has a Altman-Z score (1.72) which is in line with its industry peers.
There is no outstanding debt for BRN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 1.72
ROIC/WACCN/A
WACC9.1%

2.3 Liquidity

A Current Ratio of 1.53 indicates that BRN should not have too much problems paying its short term obligations.
The Current ratio of BRN (1.53) is better than 63.68% of its industry peers.
BRN has a Quick Ratio of 1.53. This is a normal value and indicates that BRN is financially healthy and should not expect problems in meeting its short term obligations.
BRN's Quick ratio of 1.53 is fine compared to the rest of the industry. BRN outperforms 68.40% of its industry peers.
Industry RankSector Rank
Current Ratio 1.53
Quick Ratio 1.53

2

3. Growth

3.1 Past

The earnings per share for BRN have decreased strongly by -244.36% in the last year.
BRN shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -17.13%.
BRN shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 21.68% yearly.
EPS 1Y (TTM)-244.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-42.35%
Revenue 1Y (TTM)-17.13%
Revenue growth 3Y11.51%
Revenue growth 5Y21.68%
Sales Q2Q%0.67%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

BRN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

BRN's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. BRN is more expensive than 60.38% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.9

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

3

5. Dividend

5.1 Amount

BRN has a Yearly Dividend Yield of 2.17%. Purely for dividend investing, there may be better candidates out there.
BRN's Dividend Yield is comparable with the industry average which is at 5.99.
BRN's Dividend Yield is comparable with the S&P500 average which is at 2.37.
Industry RankSector Rank
Dividend Yield 2.17%

5.2 History

The dividend of BRN decreases each year by -19.19%.
BRN has been paying a dividend for at least 10 years, so it has a reliable track record.
BRN has decreased its dividend recently.
Dividend Growth(5Y)-19.19%
Div Incr Years1
Div Non Decr Years1

5.3 Sustainability

The earnings of BRN are negative and hence is the payout ratio. BRN will probably not be able to sustain this dividend level.
DP-9.23%
EPS Next 2YN/A
EPS Next 3YN/A

BARNWELL INDUSTRIES INC

NYSEARCA:BRN (5/28/2024, 7:04:46 PM)

2.78

+0.02 (+0.72%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap27.88M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 2.17%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -9.91%
ROE -19.83%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 33.98%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.73
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.53
Quick Ratio 1.53
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-244.36%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-17.13%
Revenue growth 3Y11.51%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y